Skip to main content
Atrás
Watch Compare

Cytosorbents Corp

Calidad de datos: 83%
CTSO
Nasdaq Manufacturing Measuring & Analyzing Instruments
$0.61
▼ $0.01 (-1.63%)
Cap. Mercado: 38.31 M
Precio
$0.61
Cap. Mercado
38.31 M
Rango del Día
$0.60 — $0.62
Rango de 52 Semanas
$0.50 — $1.39
Volumen
28,956
Apertura $0.62
Promedio 50D / 200D
$0.68
9.63% below
Promedio 50D / 200D
$0.83
26.20% below

Quick Summary

Puntos Clave

Negative free cash flow of -12.54 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-79.57%
Below sector avg (-51.02%)
ROIC-31.58%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
1.61
Above sector avg (0.33)
Current Ratio2.11
Interest CoverageN/A

Valoración

PE (TTM)
-4.67
Below sector avg (-1.98)
P/B Ratio4.25
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -4.7 -2.0
P/B 4.3 5.1
ROE % -79.6 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E 1.6 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -8.20 M
ROE -79.57% ROA -17.49%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -12.54 M
ROIC -31.58% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.61 Current Ratio 2.11
Interest Coverage N/A Asset Turnover N/A
Working Capital 11.20 M Tangible Book Value 5.43 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.67 Forward P/E N/A
P/B Ratio 4.25 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -32.74%
Market Cap 38.31 M Enterprise Value 45.34 M
Per Share
EPS (Diluted TTM) -0.13 Revenue / Share N/A
FCF / Share -0.20 OCF / Share -0.20
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 152.98%
SBC-Adj. FCF -15.20 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -8.20 M -20.72 M -28.51 M -32.81 M -24.56 M
EPS (Diluted) -0.13 -0.38 -0.64 -0.75 -0.57
Gross Profit 26.49 M 25.13 M 22.39 M 20.73 M 32.12 M
Operating Income -14.75 M -16.79 M -31.21 M -31.52 M -22.74 M
EBITDA — — — — —
R&D Expenses — — 15.73 M 15.12 M 16.38 M
SG&A Expenses 35.65 M 35.00 M 33.60 M 34.29 M 35.75 M
D&A 1.23 M 1.57 M 1.46 M 882,621.0 731,578.0
Interest Expense — — — — —
Income Tax -401,000.0 -1.69 M -813,739.0 -1.09 M -736,003.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 44.18 M 47.37 M 53.26 M 63.23 M 89.52 M
Total Liabilities 38.28 M 36.26 M 29.99 M 27.86 M 26.94 M
Shareholders' Equity 5.90 M 11.11 M 23.28 M 35.37 M 62.58 M
Total Debt 16.67 M 14.00 M 5.04 M 5.00 M —
Cash & Equivalents 6.25 M 3.28 M 14.13 M 22.14 M 52.14 M
Current Assets 20.63 M 21.60 M 25.70 M 33.76 M 64.30 M
Current Liabilities 9.71 M 9.82 M 14.55 M 9.71 M 13.69 M